[1] 陈晓华,曹小龙,黎秀月,等.ALA-PDT 对食管癌Eca-109 凋亡相关基因表达的影响[J].癌症进展,2017,15(1):26-28. [2] 宋启斌,褚玉新,胡伟国,等.胸部放疗诱发放射性肺炎的影响因素分析[J].肿瘤学杂志,2016,22(2):81-84. [3] 邓建良,姚强,张云雷等.聚乙二醇化重组人粒细胞刺激因子预防化疗后中性粒细胞计数减少的临床观察[J].临床内科杂志,2017,34(4):268-270. [4] 申文江,王绿化.放射治疗损伤[M].北京:中国医药科技出版社,2001:146. [5] 王澜,李晓旭,韩春,等.食管癌长期生存患者临床特征及治疗相关因素分析[J].中华放射肿瘤学杂志,2016,25(6):565-570. [6] Machiels M, Jin P, Gurp CHV,et al.Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy[J].Rad Oncology,2018, 13(1):48. [7] 刘利珍,马康,马书田,等.不同剂量重组人粒细胞集落刺激因子注射液对恶性肿瘤化疗后白细胞下降的防治观察[J].中国医师杂志,2017,19(1):119-121. [8] Takata N, Kataoka M, Hamamoto Y,et al.Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer—comparison of four-field technique and traditional two opposed fields technique[J].J Rad Res,2018, 59(3):291-297. [9] 朱彤,饶井芬,刘承一,等.生血宁片辅助放化疗对肺癌术后患者T淋巴细胞亚群及IL-23、IL-17水平的影响[J].中国医药导报,2018,15(2):87-91.
2019, Vol. 36 
